Caps insulin copays at $35 per month

Congress file s4189-119, before Congress. Still to be decided as of 2026-08-07.

Latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 552.

What it does

Your insulin copay drops to $35 monthly Starting January 2027, insurers must cap your copay at $35 for a 30-day supply of insulin, with no deductible; after 2028, the cap becomes 25 percent of the negotiated price or $35, whichever is lower.

The bigger picture

Drug makers and insurers face new rebate rules The bill requires pharmacy benefit managers to pass all insulin rebates through to health plans, which increases pressure on drug makers to lower prices and could shift how insurers negotiate with manufacturers.

What to watch

Uninsured people still struggle to afford insulin The main protections only apply to people with health insurance; uninsured people rely on a separate pilot program and hotline, which may not reach all who need help or provide the same cost savings.

Read the official record for s4189-119

See everything up for a vote · This week in Congress · See what we have filed with the clerk